Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-06-29

FDA Approved: TRIAMTERENE AND HYDROCHLOROTHIAZIDE — Original Application (Zydus Pharmaceuticals (USA) Inc.)

View source ↗

Summary

FDA approved the original application for Triamterene and Hydrochlorothiazide from Zydus Pharmaceuticals (USA) Inc., a generic fixed-dose combination diuretic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Triamterene and Hydrochlorothiazide (Triamterene and hydrochlorothiazide)

Snippet

ORIG AP for TRIAMTERENE AND HYDROCHLOROTHIAZIDE (TRIAMTERENE AND HYDROCHLOROTHIAZIDE)